Never-before-possible opportunities across industries
Unlocking new potential in diagnostics and therapeutics.
Our opportunity in diagnostics comes from our ability to radiolabel an enormous variety of biologically-relevant molecules, often at record-breaking speed, with fluorine-18, the preferred radioisotope for PET scans.
This technology, unlocks the potential of this non-invasive molecular diagnostic technique to image virtually any disease – from cancers, neurodegenerative diseases, and cardiac anomalies – that have a known target.
Our radiolabeling platform can make PET a ubiquitous, essential, and cost-effective tool that improves decision-making and increases returns on R&D investment throughout all stages of the drug development process.
More information about this technology can be found at the website of our portfolio company Fuzionaire Diagnostics.Read More
In therapeutics, we are advancing new strategies for diseases that have been difficult to treat.
Our ionic alkali metal platform enables new classes of silicon-based therapeutics, potentially introducing a new era of silicon drugs.
Our technology provides entirely new strategies to address diseases that have historically been very difficult to target, such as Ras-driven cancers, neurodegenerative disorders such as Alzheimer's and Parkinson's, viruses, and certain other diseases.
Developing the cleanest fuels with greater energy efficiency.
Sulfur impurities that are naturally occurring in petroleum and bio-based liquid fuels can be lowered from 10,000 ppm to under 2 ppm by processing the stream through our alkali salt-based system.
Our system has also been successfully applied to processing sulfur-rich coal, and is being adapted to the low pressure and temperature desulfurization of bio-based feedstocks to create road-going biofuels without the need for blending.
Our ionic alkali metal platform has emissions reduction applications beyond just desulfurization.
Emissions reduction is a domain in which precious metal catalysts are extensively used today. Approximately 40% and 70% of global demand for platinum and palladium, respectively, is for catalytic converters.
Our ultra-cheap, Earth-abundant catalysts could also change the economics of solar fuels, which have been held back by expensive materials like platinum catalysts.
Applying our technology’s powerful ability to produce new silicon-containing materials.
Fuzionaire’s molecular science can be applied to create a wide variety of materials. We are exploring new possibilities in the automotive, aerospace, coatings, and electronics industries.